Advertisement

Pharmacy World & Science

, Volume 30, Issue 3, pp 272–277 | Cite as

Returned medicines in community pharmacies of Barcelona, Spain

  • Anna Coma
  • Pilar Modamio
  • Cecilia F. Lastra
  • Marcel L. Bouvy
  • Eduardo L. MariñoEmail author
Research Article

Abstract

Objective To monitor the amount of unused drugs and the cost to the public health system. Setting A random sample of community pharmacies in Barcelona, Spain. Method The drugs were collected from 38 community pharmacies over a period of 7 consecutive working days (excluding Sundays). A questionnaire was designed to evaluate each returned medicine. The resulting data were analyzed and evaluated. Main outcome measure The number of drugs collected at the pharmacy, the characteristics of the clients and the reasons why they returned the drugs, and finally the economic value of the drugs returned and the cost to the public health system. Results A total of 227 clients (54.6% women, 64 ± 20 years-old) returned 1,176 packages to the pharmacy. The number of packages collected in one return ranged from 1 to 121. The number of packages collected per pharmacy ranged from 0 to 188. In more than half of the cases (52.4%) the patients returned their drug in person and in 32.2% of the cases a relative returned it on their behalf. The main reason (28.2%) why drugs were returned was the expiry date. In 24.9% of the cases the patient's condition had improved and there was no further need for the drug. In 20.8% the patient had died. The estimated total cost of the collected drugs was €8,539.9. Over 75% of this amount (€6,463.9) had been paid by the public health system. Conclusion This study confirms the importance of analyzing the return of unwanted medicines to reduce unnecessary health expenditure. It also highlights the inadequacies of the Spanish health system in the areas of prescription, dispensing and use of medicines. Establishing strategies to reduce the wastage of unused medicines is necessary.

Keywords

Community pharmacy Drug expenditure Medicine waste Returned medicine Spain Unused drug 

Notes

Acknowledgements

We would like to sincerely thank the following community pharmacies of Barcelona: Albà, Alomar, Arranz, Balanyà, Bregante, Buil, Carbonell, Casalà, Castellvi, Cava, Ciurana, De Frutos, Donada, Escudero, Fiol, Flores, Frisch, Gibert-Paris, Gil, Herrero, Laporte, Mandianes, Mas, Massegué, Mesia, Mugueta, Olivart, Olivé, Puig, Rodríguez-Alsina, Rull, Sardar, Segura, Serra, Taberner, Tarrés, Veciana, Vives-Ferrer for their voluntary participation in this study.

References

  1. 1.
    Observatorio SNS. Informe anual del Sistema Nacional de Salud 2003. Madrid: Ministerio de Sanidad y Consumo, 2004. http://www.msc.es/organizacion/sns/informeAnualSNS/home.htm (last accessed 24 October 2006).
  2. 2.
    Simó-Miñana J, Gervas-Camacho J, Seguí-Díaz M, de Pablo-González R, Domínguez-Velázquez J. Spanish health care expenditure in comparison with developed Europe, 1985–2001. The Spanish Primary Care, the European Cinderella. Aten Primaria. 2004;34(9):472–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Marchiset N, Gerbaud L, Sauvant M-P, Jaffeux P, Mnhes G, Leblanc N, et al. Description des Médicaments Non Utilisés (MNU) collectés dans les pharmacies du Puy de Dome. Rev d’Epidémiol Sante Publique. 2001;49(6):551–8.Google Scholar
  4. 4.
    Ballu O. Statut des médicaments non utilisés (MNU). France: École Nationale de la Santé Publique (ENSP), Rennes; 2003. (ISBN 002B30A11).Google Scholar
  5. 5.
    Sistema Integrado de Gestión y Recogida de Envases (SIGRE). http://www.sigre.es/inicio.asp (last accessed 24 October 2006).
  6. 6.
    Braybrook S, John DN, Leong K. A survey of why medicines are returned to pharmacies. Pharm J. 1999;263:7063.Google Scholar
  7. 7.
    Grant P. Return of waste medicines to a community pharmacy. Prescriber 2001;12(4):29–38.Google Scholar
  8. 8.
    Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27(4):296–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Ekedahl ABE. Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci. 2006;28:352–8.PubMedCrossRefGoogle Scholar
  10. 10.
    WHO. ATC/DDD Index. http://www.whocc.no/atcddd (last accessed 15 September 2006).
  11. 11.
    Cameron S. Study by Alberta pharmacists indicates drug wastage a “mammoth” problem. Can Med Assoc J. 1996;155(11):1596–8.Google Scholar
  12. 12.
    Bronder E, Klimpel A. Unused drugs returned to the pharmacy-new data. Int J Clin Pharmacol Ther. 2001;39(11):480–3.PubMedGoogle Scholar
  13. 13.
    Isacson D, Olofsson C. Drugs up in smoke: a study of caseated drugs in Sweden. Pharm World Sci. 1999;21(2):96–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Ekedahl A, Wergeman L, Rydberg T. Unused drugs in Sweden measured by returns to pharmacies. J Soc-Adm-Pharm. 2003;20(1):26–31.Google Scholar
  15. 15.
    Anonym. Indicadores de la prestación farmacéutica del SNS a través de receta. Año 2003-Medidas de Farmacovigilancia. Inf Ter Sist Nac Salud. 2004;28(5):128.Google Scholar
  16. 16.
    Bouvy M, Coma A, Mariño EL, Modamio P. European survey about unused drugs. Pharm World Sci. 2005;27:A79.Google Scholar
  17. 17.
    Organization for Economic Co-operation and Development (OCDE). OCDE Health Data 2004. http://www.oecd.org/dataoecd/60/25/31819753.pdf (last accessed 15 September 2006).
  18. 18.
    Cromarty E, Downie G. Drug wastage—what is acceptable? Pharm J. 2001;267(7167):424.Google Scholar
  19. 19.
    Longmore RB, Sunderland VB, Sansom LN. Analysis of a “Medidump” campaign in Australia. Int J Pharm Pract. 1995;3:186–91.Google Scholar
  20. 20.
    Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004;38:1165–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Smith CA. Managing pharmaceutical waste: what pharmacists should know. J Pharm Soc Wisc. 2002; Nov/Dec:17–22.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Anna Coma
    • 1
  • Pilar Modamio
    • 1
  • Cecilia F. Lastra
    • 1
  • Marcel L. Bouvy
    • 2
  • Eduardo L. Mariño
    • 1
    Email author
  1. 1.Clinical Pharmacy and Pharmacotherapy Unit, Department of Pharmacy and Pharmaceutical Technology, Faculty of PharmacyUniversity of BarcelonaBarcelonaSpain
  2. 2.SIR Institute for Pharmacy Practice and PolicyLeidenThe Netherlands

Personalised recommendations